C07C 317/16
Sulfones: having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to
Official title: having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
C07C317/16 (Sulfones: having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to) appears on 843 US grants and 655 published applications in this corpus.
Search patents in C07C- Granted patents
- 843
- Published applications
- 655
- Assignees
- 411
- Inventors
- 2,458
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 6 | 0 |
| 1978 | 3 | 0 |
| 1979 | 6 | 0 |
| 1980 | 3 | 0 |
| 1981 | 9 | 0 |
| 1982 | 8 | 0 |
| 1983 | 3 | 0 |
| 1984 | 4 | 0 |
| 1985 | 9 | 0 |
| 1986 | 5 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 10 | 0 |
| 1990 | 10 | 0 |
| 1991 | 18 | 0 |
| 1992 | 27 | 0 |
| 1993 | 23 | 0 |
| 1994 | 18 | 0 |
| 1995 | 30 | 0 |
| 1996 | 12 | 0 |
| 1997 | 33 | 0 |
| 1998 | 27 | 0 |
| 1999 | 15 | 0 |
| 2000 | 23 | 0 |
| 2001 | 22 | 13 |
| 2002 | 21 | 28 |
| 2003 | 25 | 44 |
| 2004 | 26 | 43 |
| 2005 | 14 | 34 |
| 2006 | 23 | 33 |
| 2007 | 20 | 28 |
| 2008 | 20 | 35 |
| 2009 | 25 | 40 |
| 2010 | 32 | 22 |
| 2011 | 27 | 32 |
| 2012 | 34 | 22 |
| 2013 | 32 | 13 |
| 2014 | 20 | 28 |
| 2015 | 19 | 29 |
| 2016 | 17 | 19 |
| 2017 | 31 | 24 |
| 2018 | 14 | 23 |
| 2019 | 20 | 24 |
| 2020 | 13 | 17 |
| 2021 | 20 | 19 |
| 2022 | 14 | 21 |
| 2023 | 9 | 20 |
| 2024 | 17 | 24 |
| 2025 | 10 | 15 |
| 2026 | 5 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Synthetic pathway to belzutifan18 Aug 2026US 12,709,595 B2Merck Sharp & Dohme Corp.
- Compounds and photoresist compositions including the same16 Jun 2026US 12,656,679 B2Dupont Electronic Materials International, LLC
- Arylamides and methods of use thereof26 May 2026US 12,637,414 B2Genzyme Corporation
- Linker molecule and use thereof in methods for purifying peptides12 May 2026US 12,624,064 B2Gyros Protein Technologies AB
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives21 Apr 2026US 12,606,522 B2OrsoBio, Inc.
- Processes of producing volixibat and analogs thereof24 Sep 2026US 2026/0285895 A1Mirum Pharmaceuticals, Inc.
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
- Radiation-sensitive composition, method for forming pattern and onium salt compound19 Mar 2026US 2026/0079396 A1Jsr Corporation
- Prostaglandin ep4 receptor antagonist compounds15 Jan 2026US 2026/0015314 A1
- Prodrugs of Fumarates and Their Use in Treating Various Diseases1 Jan 2026US 2026/0001890 A1Alkermes Pharma Ireland Limited
Most cited
By later US patents
- Prostaglandin synthase inhibitors169US 5,593,994 AThe DuPont Merck Pharmaceutical Company · 1997
- Electrolyte materials containing highly dissociated metal ion salts168US 5,538,812 AMoltech Corporation · 1996
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- Benzene compound having 2 or more substituents87US 7,923,573 B2Daiichi Sankyo Company, Limited · 2011
- Calicheamicin mimics81US 5,550,246 AThe Scripps Research Institute · 1996